Yong Lee, DO
Family Medicine · Garden Grove, CANPI 1407007594
Payments from drug & device makers
Across 10 payments — averaging $26.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$75
- Hologic Sales And Service, LLC$48
- Amarin Pharma, Inc.$40
- Nestle Healthcare Nutrition Inc.$24
- Exact Sciences$22
- Optos, Inc.$21
- plus $34 from 2 others
What the payments were for
- Food & beverage$263100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $75 |
| Hologic Sales And Service, LLC | 2 | $48 |
| Amarin Pharma, Inc. | 2 | $40 |
| Nestle Healthcare Nutrition Inc. | 1 | $24 |
| Exact Sciences | 1 | $22 |
| Optos, Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
How this compares
$263 in reported general payments places this provider in the 50th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 142 | $133,217 |
| JanuviaSitagliptin Phosphate | 51 | $45,940 |
| CreonLipase/Protease/Amylase | 33 | $42,450 |
| FarxigaDapagliflozin Propanediol | 39 | $30,543 |
| JanumetSitagliptin Phos/Metformin Hcl | 20 | $11,124 |
| VascepaIcosapent Ethyl | 31 | $10,739 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 17 | $10,142 |
| TradjentaLinagliptin | 11 | $9,065 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,741 |
| Atorvastatin Calcium | 361 | $2,146 |
| AlogliptinAlogliptin Benzoate | 12 | $1,920 |
| Rosuvastatin Calcium | 250 | $1,745 |
| Diclofenac Sodium | 17 | $1,514 |
| Olmesartan Medoxomil | 99 | $963 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 101 | $896 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Garden Grove
- Michael DaoGarden Grove$843K
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.